Interesting - and positive - to see how this was covered in the local pharma industry daily news website this afternoon www.pharmainfocus.com.au - reference is made to the trials but not to the nature of the chemical entity i.e. cannabinoid. I take that as further evidence of the 'normalisation' of cannabis as a source of new pharmaceutical treatments (and big pharm.'s inherent interest).
Ann: Appointment of Executive Director Dr Michael Thurn, page-8
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 33.0¢ | $2.271M | 6.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83805 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 112605 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |